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rug-resistant tuberculosis in Thai children
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.Wittawatmongkol1, S. Udompornwattana2, S. Sricharoenchai1,
. Saksawad1, K. Chokephaibulkit1
Division of Infectious Diseases, Bangkok, Thailand
Buddhachinaraj Phitsanulok Hospital, Phitsanulok, Thailand
Background: Drug-resistant (DR) tuberculosis (TB) has been
merging worldwide. Drug resistant TB in children usually were
rimary resistance and reﬂected prevalence of the organism in the
ommunity. We evaluate the rate, clinical features, treatment and
utcome of DR-TB in children.
Methods:A retrospective studywas conducted in children aged
ess than 18 years who were diagnosed with TB at Siriraj hospi-
al, a tertiary care public hospital inBangkok,Thailandfrom January
008 toDecember 2011. The rate and characteristics of DR-TBwere
escribed.
Results: Of the 230 children diagnosed with TB 33 (14.3%) were
R-TB;18microbiologic conﬁrmed, and15probable, ofwhichdiag-
oses were based on exposure to drug-resistant source cases (8),
elapse TB (4) and failure to response to ﬁrst line anti-tuberculosis
rugs (3). The drug susceptibility test results were available by
ulture in 49 cases and molecular techniques (only for isoniazid
nd rifampin) in 4 cases. Of these respectively, 16/49 and 2/4 were
ound to be resistant strains. Mono-resistance of isoniazid, pyraz-
namide, and streptomycin were identiﬁed in 6 (11.3%), 5 (10.2%),
nd 2 (4%) cases, respectively.MDR-TB was identiﬁed in 3 (5.7%)
ases and poly-resistance of isoniazid and streptomycin was iden-
iﬁed in2 (3.8%) cases. In comparisonwithdrugsusceptible (DS)-TB,
hildren with DR-TB cases more likely to have underlying diseases
ther than HIV (14.2% vs 30.3%,p=0.02), receive prior TB treat-
ent (6/33 vs 2/197,p <0.001), more likely to had index cases with
esistance (9/33 in DR-TB vs 0/197 in DS-TB,p<0.001), and chest
-rays had more consolidation or atelectasis (consolidation 12.1%
s 2%,p=0.016, atelectasis 15.2% vs 3.6%,p=0.016). The mean dura-
ion of treatment was 8.0 months in DS- and 12.5 months in DR-TB
p<0.001). There was no difference in rate of cure, complete treat-
ent, or death between DS- and DR-TB.
Conclusion: DR-TB in children was not uncommon. Among
hose with drug susceptibility test results available, we found high
ate of INH mono-resistance and MDR-TB. DR-TB cases need longer
urationof treatment but nodifference in treatment outcome. Con-
rol measures are urgently needed to prevent DR-TB in children.
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Infection control: worldwide perspectives
D. Pittet
Director, Infection Control Programme and WHO Collaborating Cen-
tre on Patient Safety; External Lead, WHO First Global Patient Safety
Challenge “Clean Care is Safer Care”, Geneva, Switzerland
Health care-associated infection is a major, global issue for
patient safety and its preventionwas chosenbyWHOPatient Safety
as the theme of its First Global Patient Safety Challenge “Clean
Care is Safer Care” launched in October 2005. It occurs in every
healthcare facility in every country and affects hundreds of mil-
lions of patients annually worldwide. To date, a formal statement
has been signed by 127 ministries of health as a pledge of support
to implement actions to reduce health care-associated infection,
corresponding to a 90% coverage of theworld population. The Chal-
lenge has focused on raising global awareness of the importance of
health care-associated infection as a priority patient safety issue
with the promotion of hand hygiene as the cornerstone.
The main output of the Challenge, the WHO Guidelines on Hand
Hygiene in Health Care, includes a suite of tools to implement
the recommended multimodal improvement strategy aimed at
improving and sustaining hand hygiene. Thismodelwas developed
withinaclinical settingand furthervalidated toensureapplicability
to all healthcare settingsworldwide, irrespectiveof resources avail-
able. Embedding hand hygiene promotional activities as a national
priority is a key to sustainability.
WHO Patient Safety supports an informal network of coordina-
tors/leaders of such activities with the aim of sharing experiences
and learning from each other. At present, there are 43 “campaign-
ing countries/regions” in the network with coordinated activities
to promote hand hygiene in health care either as speciﬁc activities,
or as part of infection prevention and control activities, or patient
safety initiatives.
InMay2009,WHOPatient Safety launched the SAVE LIVES: Clean
Your Hands initiative to encourage healthcare workers to be part
of a global movement to improve and sustain hand hygiene. By
January 2012, almost 15,000 healthcare facilities had registered
their commitment to the initiative. Themajor challenge for thenext
decade will be to maintain the “snowball” effect and to show a sig-
niﬁcant impact on infection prevention across the world. To truly
protect our patients, itwill take leadership, commitment, a range of
actions, and time. The efforts of WHO, together with countries and
facilities, should help bring true ownership to healthcare workers
in relation to microorganism transmission and its prevention and,
subsequently, long-term patient safety improvement.
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